.svg){kind=small}
Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Canna Clinicals has shown a consistent performance in the Tincture & Sublingual category in New York. Over the past few months, the brand has maintained a stable position, ranking 7th in August, dropping slightly to 8th in September, and then returning to the 7th spot for October and November. This consistency in ranking suggests a stable demand for their products in this category. Despite a notable dip in sales in September, the brand managed to recover in October, achieving their highest sales figure for the period before experiencing another decline in November. This fluctuation indicates potential market volatility or shifts in consumer preferences.
Interestingly, Canna Clinicals does not appear in the top 30 brands in any other state or category, which can be seen as a limitation in their market reach. This absence could indicate either a strategic focus on the New York market or a lack of penetration in other regions. The brand's performance in the Tincture & Sublingual category in New York suggests that while they have found a niche, there is room for growth and expansion into other categories and states. Their ability to maintain a top 10 position indicates a strong presence in this specific category, but the lack of presence elsewhere highlights potential opportunities for diversification and expansion.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Canna Clinicals has experienced fluctuating rankings over the past few months, maintaining a steady position at 7th place in both October and November 2024. This stability comes after a slight dip to 8th place in September, indicating a recovery in market position. The brand faces strong competition from Veterans Choice Creations (VCC), which consistently ranks higher, reclaiming the 5th spot in November after a brief drop. Similarly, High Falls Canna New York has shown competitive resilience, swapping positions with VCC and maintaining a close race. Notably, Harney Brothers Cannabis dropped out of the top 20 in November, highlighting the volatility in this market segment. For Canna Clinicals, the challenge remains to enhance sales performance and leverage strategic marketing to climb higher in the rankings amidst these competitive dynamics.
Notable Products
In November 2024, Canna Clinicals' top-performing product was the CBD/THC 1:10 Max Strength Tincture, maintaining its position as the number one ranked product since August 2024, with sales of 197 units. The Max Strength Capsules 10-Pack consistently held the second rank over the same period. The CBD/THC/CBG 1:1:1 Relief Complex Capsules remained steady at the third rank, showing a slight decrease in sales from October to November. Notably, the CBD/THC/CBN 1:1:1 Sleep Complex Capsules, which were absent in September, returned to the fourth rank in October before disappearing again in November. Overall, the rankings have shown remarkable stability over the months, with no changes in the top three products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
